Our plans for 2024-2025

There are ten things we've set out to achieve over the next financial year that will help keep our strategy on track:

We need to stay on track to reach our strategic target to fund £15 million each year by 2028.

Our Blood Cancer Action Plan is a roadmap for how we can use data to improve survival rates and build a strong clinical and diagnostic workforce fit for the future.

We want to show the difference we’re making with an impact report that covers the full breadth of our research, advocacy and services, to tell the story about how we are measuring our impact and reporting.

We will invest in the next generation of blood cancer researchers through our new fellowships programme.

We will launch our first round of Transformational Research Awards to fund research that has the potential to make substantial progress that could transform people’s lives. We’ll make three awards, each for around £1 million over five years.

We will launch a pilot to see how healthcare professionals and people affected by blood cancer might use a direct referral to us from NHS clinical teams. By the end of 2024-2025, we will have learned from the pilot and expanded it to at least six hospitals.

We want to work out how many people with blood cancer from minority ethnic communities are able to access clinical trials. Once we know the scale of the challenge, we’ll work out how we might most effectively intervene to reduce inequality.

We want to grow our income to £20 million, ensuring that we remain on track to raise £25 million each year by 2028.

We will raise even more from our Walk of Light and Fundraise Your Way products, and we’ll focus on winning big transformative gifts from high value partners.

We will continue to increase public awareness of Blood Cancer UK to over 43% by the end of the year.

Our 2023-2024 Annual Report at a glance